Arca Biopharma Stock Triples On Plans To Test A Coronavirus TreatmentInvestors Business Daily • 05/28/20
ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated CoagulopathyGlobeNewsWire • 05/28/20
Clinical Data Evaluating Gencaro for the Treatment of Atrial Fibrillation in Heart Failure Patients Featured in Three Presentations at the 2020 Heart Rhythm Scientific SessionsGlobeNewsWire • 05/07/20
ARCA Biopharma Announces First Quarter 2020 Financial Results And Provides Corporate UpdateGlobeNewsWire • 05/06/20
Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific MeetingGlobeNewsWire • 09/11/19